Navigation Links
Kinerase Wins Allure Best of Beauty Award for 2nd Consecutive Year
Date:9/27/2011

NEW YORK, Sept. 27, 2011 /PRNewswire/ -- Kinerase, an icon of scientific skincare development, continues to provide award winning beauty for the second year in a row.  The Kinerase Restructure Firming Eye Cream has been named a winner in the 2011 Allure Best of Beauty Awards, appearing in the magazine's October 2011 issue.

(Photo:  http://photos.prnewswire.com/prnh/20110927/NY75304 )

This year, over 236 beauty products were chosen as winners across a number of categories, including skincare, hair care, cosmetics and tools. Winners were selected by Allure's editors and other industry leaders, trying thousands of products before awarding the top honors. The winning products -- which will boast the coveted Allure Best of Beauty seal of approval -- were honored by Allure at an awards ceremony Thursday night (9.15.11) at New York's Jazz at Lincoln Center.

KINERASE RESTRUCTURE FIRMING EYE CREAM:

A departure from the typical firming products, Kinerase Restructure Firming Eye Cream ($59 available at Ulta, Ulta.com, Nordstrom or Kinerase.com) visibly transforms skin by targeting elastin protein coils to lift and tone the contours of the eye area.

This luxurious Kinerase eye firming regimen combines the plant extract LOXL Stimulator, potent, clinically proven antioxidants and .15% Kinetin to improve skin elasticity and tone, tighten, and restructure for a more lifted look.  Restructure Firming Eye Cream also reduces the appearance of expression wrinkles and deeply moisturizes for firmer, smoother, more youthful-looking skin.  

About Kinerase

KINERASE® skincare provides powerful anti-aging efficacy, delivering clinically-proven visible results in gentle skin-caring formulations. The power behind Kinerase is Kinetin (N6-furfuryladenine), a plant-based antioxidant whose anti-aging properties were discovered when scientists found that it prevented plant leaves from drying out and withering. With Kinerase, indulge the luxury of skincare science to reveal youthful, radiant skin.  For more information visit http://www.kinerase.com or https://www.facebook.com/#!/Kinerase

About Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics.  More information about Valeant Pharmaceuticals International, Inc. can be found at www.valeant.com.


'/>"/>
SOURCE Kinerase
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Kinerase® Introduces "Change Your Skin, Change Your Life" Charity Campaign
2. Pelleve(TM) Wrinkle Treatment System Featured On Beauty Spaces TV Show
3. FDA: Potentially Harmful Stimulant Found in Slimming Beauty Capsules
4. CVS/pharmacy Launches ExtraCare Beauty Club
5. TRIA Beauty Leading the Charge in Bridging Gap Between Science and Skin Health
6. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
7. Federal Funding Awarded to Test Antimicrobial Properties of Copper Metals
8. Niaid / Barda Awards Elusys a $12 Million Contract to Further Develop Anthim, the Companys Anthrax Therapeutic
9. Isis Announces $1.2 Million Award to Its Ibis Subsidiary to Expand Influenza Detection Capabilities and Enable Large-Scale Influenza Transmission Studies
10. NIST Awards $2 Million to Velcura Therapeutics, Inc. for Innovative Technology R&D - Dual-Action Therapies for Bone Disease
11. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... The primary goal of this research is to analyze ... of liquid biopsy. Key information the survey seeks to ... liquid biopsy adoption amidst future users - Predominantly used ... Sample inflow to conduct liquid biopsy tests - Preference ... on. - Correlation analysis of sample type and biomarker ...
(Date:2/11/2016)... PRO-DEX, INC. (NasdaqCM: PDEX) today announced financial results for its ... also filed its Quarterly Report on Form 10-Q for the ... Exchange Commission today. --> --> ... --> Net sales for the three months ... $5.4 million from $2.8 million for the three months ended ...
(Date:2/11/2016)... 2016  Kindred Biosciences, Inc. (NASDAQ: KIN ), ... lives of pets, today announced the submission to FDA ... Drug Application (NADA) for Zimeta™ (dipyrone injection, KIND-012).  Positive ... Zimeta for the control of pyrexia (fever) in horses ... --> --> The Chemistry, Manufacturing, and ...
Breaking Medicine Technology:
(Date:2/12/2016)... ... February 12, 2016 , ... ... initiative—the Siemens Foundation-PATH Ingenuity Fellowships—to develop the advanced skills needed to introduce ... from U.S. universities who will draw from Siemens’ deep knowledge of product ...
(Date:2/12/2016)... ... ... Each year, the American Physical Therapy Association (APTA) offers a Combined Sections Meeting. ... Almost 10,000 physical therapists across the country are expected to attend this annual convention ... field and network with their colleagues. As in years past, HydroWorx is proud ...
(Date:2/12/2016)... ... February 12, 2016 , ... The ... Zuckerberg San Francisco General Hospital on April 5-7. The series is a multi-day, ... new habits. The workshops cover a broad range of topics, including coaching skills, ...
(Date:2/12/2016)... ... , ... AssureVest Insurance Group, a locally owned insurance firm with offices serving ... funds earmarked to purchase computers and software for Mrs. Harrison’s 2nd and 3rd grade ... a low-income area and has more than 60 2nd and 3rd graders with learning ...
(Date:2/12/2016)... , ... February 12, 2016 , ... ... the Pittsburgh metro area, celebrates the beginning of the latest charity campaign in ... social skills through art. Donations to this worthy cause are currently being accepted ...
Breaking Medicine News(10 mins):